 |
PDBsum entry 6t3f
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Viral protein
|
PDB id
|
|
|
|
6t3f
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
454 a.a.
|
 |
|
|
|
|
|
|
|
215 a.a.
|
 |
|
|
|
|
|
|
|
201 a.a.
|
 |
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Viral protein
|
 |
|
Title:
|
 |
Crystal structure nipah virus fusion glycoprotein in complex with a neutralising fab fragment
|
|
Structure:
|
 |
Fusion glycoprotein f0. Chain: f. Synonym: protein f. Engineered: yes. Fab66 light chain. Chain: l. Engineered: yes. Fab66 heavy chain. Chain: h.
|
|
Source:
|
 |
Nipah virus. Organism_taxid: 121791. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell_line: hek293t. Expression_system_atcc_number: crl-3216. Oryctolagus cuniculus. Rabbit. Organism_taxid: 9986.
|
|
Resolution:
|
 |
|
3.20Å
|
R-factor:
|
0.215
|
R-free:
|
0.249
|
|
|
Authors:
|
 |
V.A.Avanzato,R.Pryce,T.S.Walter,T.A.Bowden
|
|
Key ref:
|
 |
V.A.Avanzato
et al.
(2019).
A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex.
Proc Natl Acad Sci U S A,
116,
25057-25067.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
10-Oct-19
|
Release date:
|
27-Nov-19
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9IH63
(FUS_NIPAV) -
Fusion glycoprotein F0 from Nipah virus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
546 a.a.
454 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
116:25057-25067
(2019)
|
|
PubMed id:
|
|
|
|
|
| |
|
A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex.
|
|
V.A.Avanzato,
K.Y.Oguntuyo,
M.Escalera-Zamudio,
B.Gutierrez,
M.Golden,
S.L.Kosakovsky Pond,
R.Pryce,
T.S.Walter,
J.Seow,
K.J.Doores,
O.G.Pybus,
V.J.Munster,
B.Lee,
T.A.Bowden.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Nipah virus (NiV) is a highly pathogenic paramyxovirus that causes frequent
outbreaks of severe neurologic and respiratory disease in humans with high case
fatality rates. The 2 glycoproteins displayed on the surface of the virus, NiV-G
and NiV-F, mediate host-cell attachment and membrane fusion, respectively, and
are targets of the host antibody response. Here, we provide a molecular basis
for neutralization of NiV through antibody-mediated targeting of NiV-F.
Structural characterization of a neutralizing antibody (nAb) in complex with
trimeric prefusion NiV-F reveals an epitope at the membrane-distal domain III
(DIII) of the molecule, a region that undergoes substantial refolding during
host-cell entry. The epitope of this monoclonal antibody (mAb66) is primarily
protein-specific and we observe that glycosylation at the periphery of the
interface likely does not inhibit mAb66 binding to NiV-F. Further
characterization reveals that a Hendra virus-F-specific nAb (mAb36) and many
antibodies in an antihenipavirus-F polyclonal antibody mixture (pAb835) also
target this region of the molecule. Integrated with previously reported
paramyxovirus F-nAb structures, these data support a model whereby the
membrane-distal region of the F protein is targeted by the antibody-mediated
immune response across henipaviruses. Notably, our domain-specific sequence
analysis reveals no evidence of selective pressure at this region of the
molecule, suggestive that functional constraints prevent immune-driven sequence
variation. Combined, our data reveal the membrane-distal region of NiV-F as a
site of vulnerability on the NiV surface.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |